Croda International Plc Results for 6 months to 30 June 2004.

Slides:



Advertisements
Similar presentations
Clinical study with GOLD COLLAGEN Effects and compatibility of Gold Collagen in anti-ageing & skin treatments Dr. med. Angelika Rietz DERMATOLOGIST.
Advertisements

Atlas Copco Group Q2 Results July 16, Contents  Q2 business highlights  Market development  Business areas  Financials  Outlook 2 July 16,
July 17, 2009, Atlas Copco Group Q2 Results July 17, 2009.
July 18, 2008, Atlas Copco Group Q2 Results July 18, 2008.
Preliminary Results 26 May Ian Much Chief Executive.
Presentation of Results for the year ended 31 st March th June 2001 Johnson Matthey.
P R E L I M I N A R Y R E S U L T S 1 March 2006.
P R E L I M I N A R Y R E S U L T S 7 March 2007.
GEORGE WIMPEY PLC Interim Results for the half year ended 30 June 2001 Tuesday 31 July 2001.
INTERIM REPORT 2006/07 4th December 2006 Presentation to Analysts and Investors.
I N T E R I M R E S U L T S 8 September Financial highlights 6 months to June 2004 £ million Half Half% inc. Group sales %
P R E L I M I N A R Y R E S U L T S 3 March 2004.
I N T E R I M R E S U L T S September months to June 2005 £ million Half Half% inc. Group sales % Operating profit before.
Module 3: Financial Statement Analysis ACG 2071 Fall 2007 Created by M. Mari.
Interim Results 6 September John Neilson Finance Director.
Filtrona plc Full Year Results Year ended 31 st December 2008.
Presentation to Carillion The Equipment Rental Specialists 9 th June 2010 The Equipment Rental Specialists Vp plc Final Results for the year ended 31 March.
I N T E R I M R E S U L T S 3 September Financial Highlights 6 months to June 2003 £ million Half Half% inc. Sales – continuing operations %
Presentation of Results for the year ended 31 st March th June 2000 Johnson Matthey.
1 1 Analyst Presentation Quarter Agenda Financial highlights Macro Environment Operating performance highlights Financial review.
WILDERNESS HOLDINGS – AUDITED YEAR END RESULTS 2010 INTERIM RESULTS ANNOUNCEMENT Six months ended 31 August 2012.
P R E L I M I N A R Y R E S U L T S March £ million % inc. Group sales % Operating profit % Operating margin14.3%14.4%
DAIRY CREST GROUP PLC PRELIMINARY RESULTS TO 31 March 2002 Delivering added value growth and attractive returns for shareholders.
Creating and Delivering Solutions for our Customer’s Success Creating and Delivering Solutions for our Customers’ Success Investor Briefing FY2009 H1 February.
Annual Results 2010 Financial year ended 28 February 2010.
Presentation of Results for the half year ended 30 th September th November 2001 Johnson Matthey.
 McBride plc Key Message Business Strategy has again delivered Full Year Profit, Cash and Dividends in line with market expectations.
The SKF Group Half-year result, 2005 Tom Johnstone, President and CEO.
1 The world’s leading manufacturer of collagen products for the food industry 2008 Interim Results Presentation 28 August 2008.
Atlas Copco Group Q3 Results October 22, Q3 - highlights  Strong order growth –Sequentially higher volumes in all regions and in most customer.
Presentation of Results for the year ended 31 st March th June 2003 Johnson Matthey 
0 15 July The SKF Group Half-year results 2008 Tom Johnstone, President and CEO.
13 February 2008 Company confidential Results 4Q07 and FY07 Martin De Prycker, CEO 13 February 2008.
 Fixed (Indirect/Overheads) – are not influenced by the amount produced but can change in the long run e.g., insurance costs, administration, rent,
VALUATION MEASURING AND MANAGING THE VALUE OF COMPANIES
Tullett Prebon plc Preliminary Results 2006 March 2007 Terry Smith, Chief Executive Paul Mainwaring, Finance Director.
Johnson Matthey Presentation of Results for the year ended 31st March th June 1999.
Presentation of Results for the half year ended 30 th September th November 2000 Johnson Matthey E.
22 October 2008 Slide 1 Results 3Q08 Results 3Q08 Martin De Prycker, CEO 22 October 2008.
WARM UP 12/4 1. Give 3 functions of sebaceous glands. 2. What is an autograft? 3. A chemical that gives skin its color. 4. What are four things found in.
Atlas Copco Group Q results January 31, 2013.
Atlas Copco Group Q2 Results July 18, Q2 - highlights  Very strong organic order growth –Record orders received –Favorable demand in mining, manufacturing.
The SKF Group First-quarter result 2005 Tom Johnstone, President and CEO.
Atlas Copco Group Q3 Results October 21, Q3 - highlights  Overall demand remained at a high level –Solid development in manufacturing and mining.
Atlas Copco Group Q2 Results July 17, Contents  Q2 Business Highlights  Market Development  Business Areas  Financials  Outlook.
Atlas Copco Group Q4 Results February 2, Contents  2003 Summary  Q4 Business Highlights  Market Development  Business Areas  Financials 
Croda International Plc 2001 Preliminary Results.
Croda International Plc Transition to International Accounting Standards.
Croda International Plc Results for 12 months to 31 December 2006.
Croda International Plc Results for 6 months to 30 June 2006.
Croda International Plc 2002 Preliminary Results.
Croda International Plc 2000 Preliminary Results.
Top Hair Care Products for Healthy Hair. What are The Best Hair Care Products  The best hair care products out on the market are a result of innovative.
Croda International Plc Preliminary Results 2005.
Croda International Plc Results for 6 months to 30 June 2003.
Croda International Plc Results for 6 months to 30 June 2001.
Croda International Plc 2003 Preliminary Results.
Croda International Plc Results for 6 months to 30 June 2002.
July 16, Atlas Copco Group Q2 Results July 16, 2004.
Croda International Plc
GRACO INC. 4th Quarter 2009 Earnings Conference Call Tuesday,
Lesson Aims List the different parts of the hair
H1/Q Financial Results.
Results 4Q04 and FY04 Martin De Prycker CEO February 17, 2005
Presentation of Results for the half year ended 30th September 2002
Presentation of Results for the year ended 31st March 2001
Presentation of Results for the half year ended 30th September 2003
Preliminary Results 5 March 2008
The SKF Group Year-end result 2003 Tom Johnstone President and CEO.
Interim results Six months ended 31st October th December 2004
Presentation transcript:

Croda International Plc Results for 6 months to 30 June 2004

Summary 10% growth in continuing operations sales in constant currency 14% growth in Personal and Health Care sales in constant currency Oleochemical trading margins of 17.7% £8.6m reduction in net debt to £20.4m

Summary of continuing operations Sales Operating profit Interest(1.2)(1.7) Profit before tax £m

Statistics EPS normalised (p) DPS (p) Cash flow per share (p) Tax rate (%)

Sales by destination* £m%£m% United Kingdom Rest of Europe Americas Asia Rest of World _______________________________ _______________________________ * continuing operations only

Sales by market* Personal & Health Care Home Care & Plastics Additives Industrial Specialities Other _________ ______ _________ ______ __________ ______ _________ ______ * continuing operations only £m% £m %

Turnover change on prior year* % Volume Currency Mix/ Total price Oleo Other Total * continuing operations only

Oleo value/volume change* % ofValue Volume Sales % % 65Personal & Health Care Home Care and Plastics Additives Industrial Specialities ______ 100 ______ * continuing operations only

Exceptional Items Sale of Fire Fighting(3.8) Sale of surplus properties1.3 ______ (2.5) ______ Non-cash(3.6) Cash1.1 _______ ( 2.5) _______ £m

Oleochemicals trading margin* * continuing operations only

Cash flow £m Operating cash flow Interest(1.2)(1.7) Dividends(4.6)(4.5) Taxation(7.3)(7.0) _______ _______ Free cash flow Capex(8.9)(4.4) Own shares1.0(0.6) Disposals/Acquisitions/Closures 5.3(0.4) _______ _______ Net cash flow Other(0.1)1.3 _______ _______ Reduction in net debt _______ _______

Summary of trading Personal and Health Care driving growth Many new launches by customers in first half Positive price/mix effect Negative currency impact Very good growth in USA

Business development

New products Haloxyl Procapil Coltide

HALOXYL ™ Under eye circle reduction

What are dark circles? An accumulation of haemoglobin and its coloured degradation products in the dermis and epidermis including iron and bilirubin

How does Haloxyl work? Reinforcement and tone of the eye area Forms a complex with the iron to enable its elimination Stimulates the enzyme involved in the clearance of bilirubin

Clinical study: decrease of dark-circle colour 22 female volunteers with dark-circles (Average age 32.7 years) Twice daily application of a gel with 2% Haloxyl™ to the contour of one eye Application of a placebo on the other side 56 days Assessment of the under eye colour by image analysis Measurement of colour parameters by specific software ΔaΔbΔaΔb The natural colour of the skin is subtracted from the measured values

Significant decrease of dark-circle colour after a 2-month treatment with 2% HALOXYL™ Haloxyl TM 2%Placebo Haloxyl TM 2%

HALOXYL™ enables anti-pigment and restructuring treatment of the fragile connective tissues around the eyes. Its anti-inflammatory effect contributes to reducing the vasodilation and resulting capillary leakages. After 2 months, HALOXYL ™ provided a very significant decrease in the violet coloration of the infra-orbital rings.

PROCAPIL ™ ANTI-AGEING Cell dynamics promote hair anti-ageing and prevent hair loss

PROCAPIL ™ ANTI-AGEING Hair anti-ageing promoted by stimulation of the hair follicle cell metabolism: the synthesis of adhesion molecules, the keratinocyte multiplication Slowdown in hair loss by: increase of the proportion of anagen hair for 67% volunteers, reinforcement of the epithelium sheath and hair bulb.

anagen phasecatagen phasetelogen phase Normal hair ~ 4 years ~ 3 week ~ 4 months 85% 1% 14% Alopecic hair shorter longer 60-80% 20-40% Hair growth cycle

4 month in-vivo study 35 male volunteers with alopecia 18 volunteers applied 3% PROCAPIL ™ in a hair lotion 17 volunteers applied a placebo Videotrichogramme and morphological study Ratio A/T (phase A: anagen phase of growth, phase T: telogen phase of loss) Day 0: hair cutDay 2 :Telogen hairAnagen hair

Videotrichogramme Ratio A/T PROCAPIL ™ 3% Placebo T T 4 months With the PROCAPIL™ treatment, 67% volunteers present more numerous anagen hair. The A/T ratio varies significantly compared to T0 and the placebo up to 46%.

PROCAPIL ™ - T0 PROCAPIL ™ - T 4 months Morphological study of hair between T0 and T 4 months Bulb of a telogen hair Epithelium sheath of an anagen hair With the PROCAPIL™ treatment: The hair bulb cell layers are differentiated and thicker HAIR BULBS AND ANCHORING IS REINFORCED

Coltide “easy iron” Protein Silicone Copolymer Cross links to form polymeric film on surface of fabric Reduces surface friction to enable ‘easy iron’ Prevents thermal damage Protein structure aids moisture retention

Iron Test Device Cotton Fabric Measure force to pull iron across fabric Test procedure

Test results Coltide improves ease of ironing Wash only Wash and conditioner plus Coltide

Cost Base Raw materials higher Pensions and insurance flat Energy costs rising

Diverse customer base * continuing operations only % Sales

Outlook Strong growth in Personal Care Price increases holding Health Care continues to progress New products Innovation pays